Activated prothrombin complex concentrate (APCC)-mediated activation of factor (F)VIII in mixtures of FVIII and APCC enhances hemostatic effectiveness-Reference-Cited by-同舟云学术

Activated prothrombin complex concentrate (APCC)-mediated activation of factor (F)VIII in mixtures of FVIII and APCC enhances hemostatic effectiveness

Published:2013-05 Issue:5 Volume:11 Page:902-910
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

Yada K.¹,Nogami K.¹,Ogiwara K.¹,Shima M.¹

Affiliation:

1. Department of Pediatrics; Nara Medical University; Kashihara Nara Japan

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12197/fullpdf

Reference20 articles.

1. Surface-dependent reactions of the vitamin K-dependent enzyme complexes;Mann;Blood,1990

2. The factor VIII complex: structure and function;Hoyer;Blood,1981

3. Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity;Eaton;Biochemistry,1986

4. Association of the factor VIII light chain with von Willebrand factor;Lollar;J Biol Chem,1988

5. Risk factors for inhibitor development in hemophilia A;Oldenburg;Haemotologica,2000

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro effects of combining Mim8 with factor VIII, FVIIa, and activated prothrombin complex concentrates in thrombin generation assays;Journal of Thrombosis and Haemostasis;2023-06

2. Potential role of activated factor VIII (FVIIIa) in FVIIa/tissue factor-dependent FXa generation in initiation phase of blood coagulation;International Journal of Hematology;2019-02-13

3. Factor (F)VIII/VIIa enhances global haemostatic function in the co-presence of bypassing agents and FVIII among patients with haemophilia A with inhibitor;British Journal of Haematology;2018-04-02

4. A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents;Journal of Clinical Medicine;2018-02-11

5. Combination of hemostatic therapies for treatment of patients with hemophilia A and inhibitors;Blood Cells, Molecules, and Diseases;2017-07